For the quarter ending 2026-03-31, HIMS had -$6,350K decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net (loss) income | -92,115 | 20,601 | 15,774 | 42,505 |
| Depreciation and amortization | 21,953 | 18,092 | 17,669 | 10,465 |
| Stock-based compensation | 36,862 | 34,488 | 40,172 | 35,726 |
| Change in fair value of equity securities | -9,682 | 4,437 | - | - |
| Change in fair value of liabilities | 17,646 | 1,629 | 7,626 | - |
| Net accretion on securities | 242 | 719 | 253 | 367 |
| Benefit from deferred taxes | -13,975 | -3,477 | 862 | -9,456 |
| Impairment of long-lived assets | - | 0 | 531 | 0 |
| Amortization of debt discount and issuance costs | 1,701 | 1,739 | 1,743 | 1,047 |
| Non-cash operating lease cost | -4,582 | -4,508 | -3,311 | -2,689 |
| Non-cash acquisition-related costs | 6,367 | 932 | 1,976 | 1,955 |
| Non-cash restructuring and other related charges included within cost of revenue | 28,462 | - | - | - |
| Non-cash other | -982 | 6 | 814 | 2,147 |
| Receivables, net | 116,247 | - | - | - |
| Inventory | 20,303 | -26,381 | -37,270 | 65,704 |
| Prepaid expenses and other current assets | -645 | -2,526 | 16,301 | 20,842 |
| Other long-term assets | 8,364 | 513 | -5 | 83 |
| Accounts payable | 167,643 | -45,801 | 70,952 | -9,327 |
| Accrued liabilities | 10,016 | -1,907 | -52,883 | 7,386 |
| Deferred revenue | 37,980 | 8,525 | 19,947 | -12,348 |
| Earn-out payable | -2,058 | - | - | - |
| Operating lease liabilities | -1,861 | -1,249 | 1,134 | -616 |
| Earn-out payable | - | 0 | 0 | 0 |
| Net cash provided by operating activities | 89,356 | 61,312 | 148,721 | -19,117 |
| Purchases of available-for-sale investments | - | 12,282 | 713,556 | 0 |
| Maturities of available-for-sale investments | 93,253 | 35,941 | 12,188 | 29,227 |
| Proceeds from sales of available-for-sale investments | 76,708 | 0 | 0 | - |
| Purchases of property, equipment, and intangible assets | 29,844 | 59,388 | 65,265 | 46,065 |
| Investment in website development and internal-use software | 6,480 | 4,493 | 4,092 | 4,250 |
| Acquisition of businesses, net of cash acquired | 137,866 | 23,454 | 116,673 | 0 |
| Purchases of equity securities | 11,217 | 20,000 | - | - |
| Net cash used in investing activities | -15,446 | -83,676 | -887,398 | -21,088 |
| Proceeds from issuance of convertible senior notes, net of debt discount | - | 0 | 0 | 970,000 |
| Purchases of capped calls related to convertible senior notes | - | 0 | 0 | -47,800 |
| Proceeds from exercise of vested stock options | 5,008 | 1,237 | 3,299 | 2,569 |
| Payments for taxes related to net share settlement of equity awards | 39,206 | 21,714 | 32,480 | 36,764 |
| Repurchases of common stock | - | 80,481 | 9,479 | 0 |
| Payments for acquisition-related earn-out consideration | 43,682 | 0 | 0 | 0 |
| Proceeds from employee stock purchase plan | - | 3,470 | 0 | 2,970 |
| Proceeds from exercise of class a common stock warrants | - | 0 | - | - |
| Payments for debt issuance costs | 0 | 34 | 349 | 1,806 |
| Net cash used in financing activities | -77,880 | -97,522 | -39,009 | 889,169 |
| Foreign currency effect on cash and cash equivalents | -2,380 | 2,724 | -1,486 | 1,027 |
| (decrease) increase in cash, cash equivalents, and restricted cash | -6,350 | -117,162 | -779,172 | 849,991 |
| Cash, cash equivalents, and restricted cash at beginning of period | 228,616 | 345,778 | 1,124,950 | 274,959 |
| Cash, cash equivalents, and restricted cash at end of period | 222,266 | 228,616 | 345,778 | 1,124,950 |
Hims & Hers Health, Inc. (HIMS)
Hims & Hers Health, Inc. (HIMS)